Viriom
Developing novel and affordable therapies against life threatening infections such as HIV and HBV
Total raised
€1.9M
€1,950,000
Funding rounds
1
Investors
2
distinct backers
Active since
2016-04
latest 2016-04
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood15
base rate 42% for Early VC
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2016-05-01 | Early VC | €1.9M | ChemRar Ventures,Torrey Pines Investment | View deal → |
Investors
2Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Oura Health€779MFinland · Healthtech
- Doctolib€734MFrance · E-commerce